In ERα‐positive breast cancers, however, an increased proportion of ERα‐expressing cells appears to be proliferating, due to a shift from a paracrine to an autocrine regulation of proliferation by ERα [49, 52]. The gene discussed is ESR1; the disease is breast carcinoma.